Huilin Tang

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Venues

Diabetes, obesity & metabolism

Journal of the American Heart Association

Diabetes care

Annals of internal medicine

Peking University Health Science Centre

Peking University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Peking University Health Science Centre

China

Adjunct Researcher :: Institute for Drug Evaluation

Indiana University Sep 01 2015

United States

Research associate :: Department of Epidemiology

Peking University Third Hospital Aug 01 2011 - Sep 01 2017

China

Clinial pharmacist :: Department of Pharmacy

Education History

Peking University Sep 01 2008 - Jul 01 2011

China

MSC :: Peking University Third Hospital

Publications

Serena Jingchuan Guo, Huilin Tang, Stephen R Benoit, Ying Lu, Lizheng Shi, Vivian A Fonseca, Hwayoung Cho, Yi Guo, Jiang Bian
Sodium-glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real-world patients with type 2 diabetes. Diabetes, obesity & metabolism (2024)
Huilin Tang, Ying Lu, William Troy Donahoo, Hui Shao, Lizheng Shi, Vivian A Fonseca, Yi Guo, Jiang Bian, Serena Jingchuan Guo
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes : A Target Trial Emulation Study. Annals of internal medicine 177 (8) (2024)
Huilin Tang, Ying Lu, William Troy Donahoo, Hui Shao, Lizheng Shi, Vivian A Fonseca, Yi Guo, Jiang Bian, Serena Jingchuan Guo
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes : A Target Trial Emulation Study. Annals of internal medicine (2024)
Ying Lu, Huilin Tang, Pareeta Kotecha, Hwayoung Cho, William T Donahoo, Jiang Bian, Serena Jingchuan Guo
Newer glucose-lowering drugs and risk of suicidal ideation and behaviours: A network meta-analysis of randomized outcome trials. Diabetes, obesity & metabolism (2024)
Ying Lu, Huilin Tang, Pareeta Kotecha, Hwayoung Cho, William T Donahoo, Jiang Bian, Serena Jingchuan Guo
Newer glucose-lowering drugs and risk of suicidal ideation and behaviours: A network meta-analysis of randomized outcome trials. Diabetes, obesity & metabolism (2024)
Huilin Tang, Wei-Han Chen, Jiang Bian, LaToya J O'Neal, Daniel T Lackland, Desmond A Schatz, Serena Jingchuan Guo
Ethnic Variations in Cardiovascular and Renal Outcomes From Newer Glucose-Lowering Drugs: A Meta-Analysis of Randomized Outcome Trials. Journal of the American Heart Association 12 (10) (2023)
Huilin Tang, Wei-Han Chen, Jiang Bian, LaToya J O'Neal, Daniel T Lackland, Desmond A Schatz, Serena Jingchuan Guo
Ethnic Variations in Cardiovascular and Renal Outcomes From Newer Glucose-Lowering Drugs: A Meta-Analysis of Randomized Outcome Trials. Journal of the American Heart Association (2023)
Huilin Tang, Wei-Han Chen, Jiang Bian, LaToya J O'Neal, Daniel T Lackland, Desmond A Schatz, Serena Jingchuan Guo
Ethnic Variations in Cardiovascular and Renal Outcomes From Newer Glucose-Lowering Drugs: A Meta-Analysis of Randomized Outcome Trials. Journal of the American Heart Association 12 (10) (2023)
Huilin Tang, Wei-Han Chen, Jiang Bian, LaToya J O'Neal, Daniel T Lackland, Desmond A Schatz, Serena Jingchuan Guo
Ethnic Variations in Cardiovascular and Renal Outcomes From Newer Glucose-Lowering Drugs: A Meta-Analysis of Randomized Outcome Trials. Journal of the American Heart Association 12 (10) (2023)
Huilin Tang, Wei-Han Chen, Jiang Bian, LaToya J O'Neal, Daniel T Lackland, Desmond A Schatz, Serena Jingchuan Guo
Ethnic Variations in Cardiovascular and Renal Outcomes From Newer Glucose-Lowering Drugs: A Meta-Analysis of Randomized Outcome Trials. Journal of the American Heart Association (2023)
Huilin Tang, Wei-Han Chen, Jiang Bian, LaToya J O'Neal, Daniel T Lackland, Desmond A Schatz, Serena Jingchuan Guo
Ethnic Variations in Cardiovascular and Renal Outcomes From Newer Glucose-Lowering Drugs: A Meta-Analysis of Randomized Outcome Trials. Journal of the American Heart Association 12 (10) (2023)
Huilin Tang, Stephen E Kimmel, Steven M Smith, Kenneth Cusi, Weilong Shi, Matthew J Gurka, Almut G Winterstein, Serena Jingchuan Guo
Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials. Diabetes care 45 (4) (2022)
Huilin Tang, Keming Yang, Xin Li, Yiqing Song, Jiali Han
Pancreatic safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Pharmacoepidemiology and drug safety 29 (2) (2021)
Huilin Tang, Stephen E Kimmel, Inmaculada Hernandez, Maria M Brooks, Kenneth Cusi, Steven M Smith, Weilong Shi, Almut G Winterstein, Jared W Magnani, Serena Jingchuan Guo
Are novel glucose-lowering agents' cardiorenal benefits generalizable to individuals of Black race? A meta-trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment. Diabetes, obesity & metabolism 24 (1) (2021)
Huilin Tang, Liyuan Zhou, Xiaotong Li, Alan C Kinlaw, Jeff Y Yang, Andrew M Moon, Edward L Barnes, Tiansheng Wang
Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data. International journal of clinical pharmacy 43 (4) (2021)
Dandan Li, Tingxi Wu, Tiansheng Wang, Hongtao Wei, Aihua Wang, Huilin Tang, Yiqing Song
Effects of sodium glucose cotransporter 2 inhibitors on risk of dyslipidemia among patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Pharmacoepidemiology and drug safety 29 (5) (2020)
Tiansheng Wang, Jeff Y Yang, John B Buse, Virginia Pate, Huilin Tang, Edward L Barnes, Robert S Sandler, Til Stürmer
Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults. Diabetes care 42 (11) (2019)
Aihua Wang, Keming Yang, Tiansheng Wang, Ning Zhang, Huilin Tang, Xin Feng
Effects of sodium-glucose cotransporter 2 inhibitors on risk of venous thromboembolism in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes/metabolism research and reviews 36 (1) (2019)
Guangyao Li, Matthew J Crowley, Huilin Tang, Jeff Y Yang, Robert S Sandler, Tiansheng Wang
Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials. Diabetes care 42 (7) (2019)
Huilin Tang, Guangyao Li, Ying Zhao, Fei Wang, Emily W Gower, Luwen Shi, Tiansheng Wang
Comparisons of diabetic retinopathy events associated with glucose-lowering drugs in patients with type 2 diabetes mellitus: A network meta-analysis. Diabetes, obesity & metabolism 20 (5) (2018)
Huilin Tang, Deming Li, Yufeng Li, Xi Zhang, Yiqing Song, Xinli Li
Effects of Vitamin D Supplementation on Glucose and Insulin Homeostasis and Incident Diabetes among Nondiabetic Adults: A Meta-Analysis of Randomized Controlled Trials. International journal of endocrinology 2018 (2018)
Dandan Li, Weilong Shi, Tiansheng Wang, Huilin Tang
SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 20 (8) (2018)
Tiansheng Wang, Wenchao Lu, Huilin Tang, John B Buse, Til Stürmer, Emily W Gower
Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System. Diabetes care 42 (2) (2018)
Huilin Tang, Keming Yang, Yiqing Song, Jiali Han
Meta-analysis of the association between sodium-glucose co-transporter-2 inhibitors and risk of skin cancer among patients with type 2 diabetes. Diabetes, obesity & metabolism 20 (12) (2018)

Huilin Tang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Huilin Tang